Darifenacin HBr
CAS No. 133099-07-7
Darifenacin HBr( UK 88525-04 )
Catalog No. M11319 CAS No. 133099-07-7
Darifenacin is a selective muscarinic receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 38 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDarifenacin HBr
-
NoteResearch use only, not for human use.
-
Brief DescriptionDarifenacin is a selective muscarinic receptor antagonist.
-
DescriptionDarifenacin is a selective muscarinic receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsUK 88525-04
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorM3 mAChR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number133099-07-7
-
Formula Weight505.45
-
Molecular FormulaC28H31BrN2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 117 mg/mL (230.56 mM)
-
SMILESC1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moriya H, et al. Life Sci. 1999; 64(25):2351-8.
molnova catalog
related products
-
Erdosteine
Erdosteine is a mucolytic. Erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis.
-
SEN 12333
α7 nicotinic acetylcholine receptor (nAChR) agonist.
-
PNU 282987
PNU-282987 is a selective α7 nicotinic acetylcholine receptor(α7 nAChR) agonist with Ki of 26 nM; no affinity for α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM).
Cart
sales@molnova.com